Skip to content

Axel Mann

  • Scientist
  • University of Zurich, Institute of Medical Virology
  • 5PublicationsNumber of items in Axel's My Publications folder on Mendeley.
  • 18Followers

Followers (18)

Explore network

Following (20)

Explore network

Publications (5)

  • Conformation-Dependent Recognition of HIV gp120 by Designed Ankyrin Repeat Proteins Provides Access to Novel HIV Entry Inhibitors.

    • Mann A
    • Friedrich N
    • Krarup A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1.

    • Ruprecht C
    • Krarup A
    • Reynell L
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Divergent effects of cell environment on HIV entry inhibitor activity.

    • Rusert P
    • Mann A
    • Huber M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • HIV sensitivity to neutralization is determined by target and virus producer cell properties.

    • Mann A
    • Rusert P
    • Berlinger L
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.

    • Schweizer A
    • Rusert P
    • Berlinger L
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Scientist

University of Zurich, Institute of Medical Virology

February 2012 - Present

PhD Student

University of Zurich, Institute of Medical Virology

April 2007 - January 2012(5 years)

Research Intern

Roche

April 2006 - December 2006(8 months)

Education

PhD

University of Zurich

April 2007 - January 2012(5 years)

Diplom Biologie (M.Sc.)

University of Regensburg

October 2000 - February 2006(5 years)

Université Paris Descartes - Paris 5

September 2003 - March 2004(6 months)